TrialInternational journal of hematology2017

Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report.

Hirohisa Nakamae et al.PubMed ↗Publisher ↗

No numbers read from the abstract.